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ABSTRACT
Gonadotropin-releasing hormone (GnRH) neurons provide a
fundamental signal for the onset of puberty and subsequent
reproductive functions by secretion of gonadotropin-releasing
hormone. Their disrupted development or function leads to
congenital hypogonadotropic hypogonadism (CHH). To model the
development of human GnRH neurons, we generated a stable
GNRH1-TdTomato reporter cell line in human pluripotent stem cells
(hPSCs) using CRISPR-Cas9 genome editing. RNA-sequencing of
the reporter clone, differentiated into GnRH neurons by dual SMAD
inhibition and FGF8 treatment, revealed 6461 differentially expressed
genes between progenitors and GnRH neurons. Expression of the
transcription factor ISL1, one of the top 50 most upregulated genes
in the TdTomato-expressing GnRH neurons, was confirmed in 10.5
gestational week-old human fetal GnRH neurons. Among the
differentially expressed genes, we detected 15 genes that are
implicated in CHH and several genes that are implicated in human
puberty timing. Finally, FGF8 treatment in the neuronal progenitor
pool led to upregulation of 37 genes expressed both in progenitors
and in TdTomato-expressing GnRH neurons, which suggests
upstream regulation of these genes by FGF8 signaling during
GnRH neuron differentiation. These results illustrate how hPSC-
derived human GnRH neuron transcriptomic analysis can be utilized
to dissect signaling pathways and gene regulatory networks involved
in human GnRH neuron development.
This article has an associated First Person interview with the first
author of the paper.
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INTRODUCTION
Hypothalamic gonadotropin-releasing hormone (GnRH) neurons
are a central part of the hypothalamus-pituitary-gonadal (HPG) axis
that regulates reproduction. GnRH secretion is periodically
activated during fetal development, postnatally during
‘minipuberty’, and during adolescence (Kuiri-Hanninen et al.,
2014; Young et al., 2019). At puberty, GnRH neurons are gradually
reactivated, which increases pituitary gonadotropin and ultimately
gonadal sex steroid production. Disruption of GnRH signaling,
secretion or GnRH neuron development can lead to congenital
hypogonadotropic hypogonadism (CHH), which is characterized by
partial or absent puberty, incomplete development of sexual
characteristics and often infertility. Patients with CHH combined
with anosmia/hyposmia (absent or reduced sense of smell) acquire
Kallmann Syndrome (KS) diagnosis (Boehm et al., 2015; Young
et al., 2019). Approximately half of the patients can be diagnosed at
the molecular level, which suggests the existence of numerous
unknown genetic and biological mechanisms controlling puberty.
The first major characterization of human embryonic GnRH
neuron localization and migratory route from the frontonasal
mesenchyme outside the olfactory and presumptive vomeronasal
epithelia to the brain was published in 2016 (Casoni et al., 2016).
The newly formed GnRH neurons can only be detected after their
delamination from the neuroepithelium into the nasal mesenchyme,
and the subpopulation of neuronal progenitors that give rise to
GnRH neurons and their gene expression profile are yet to be
described (Tucker et al., 2010; Wray, 2010; Forni and Wray, 2015).
We have recently reported a protocol for the generation of GnRH-
expressing and -secreting neurons from human pluripotent stem
cells (hPSCs), in which treatment with FGF8 at the neuronal
progenitor stage leads to high expression of anterior neuronal
markers such as FOXG1 and, after further differentiation, these cells
give rise to GnRH-expressing neurons (Lund et al., 2016). FGF8 is
the growth factor with most potential to have a role in GnRH neuron
ontogeny and differentiation, emphasized by the discovery of FGF8
and FGFR1 mutations that cause KS and CHH (Chung et al., 2008;
Falardeau et al., 2008). The identity of the neuronal progenitor
subtype that gives rise to GnRH neurons has not been well
characterized. In this study, we generated a GnRH-TdTomato
reporter hPSC line using CRISPR-Cas9 technology. The reporter
cell line has allowed us to isolate GNRH1-expressing neurons by
fluorescence activated cell sorting (FACS) and to investigate their
mRNA transcriptomes by RNA-sequencing (RNA-seq).
To shed light on the gene expression of the human putative GnRH
neuron progenitor subtype and early postmitotic GnRH neurons, we
first investigated the differential expression between the FGF8-
treated neuronal progenitor pool and TdTomato-expressing GnRH
neurons. Second, we used comparison with non-FGF8-treatedReceived 12 April 2019; Accepted 16 January 2020
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neuronal progenitors to investigate the putative effects of FGF8-
treatment; in both the progenitor pool and in postmitotic GnRH
neurons.
The results presented in this study include a large number of
differentially expressed genes not previously described in GnRH
neurons, which expands the list of candidate regulators of human
GnRH neuron development. We have highlighted some potential
genes of particular interest in regards to GnRH neuron development
and disease modeling. This provides new insight into early stages
of human GnRH neuron development and the possibility of
identifying markers expressed specifically in GnRH neurons.
RESULTS
GNRH1-TdTomato reporter cell line generated using
CRISPR-Cas9
To enable the detection and isolation of hPSC-derived GnRH
neurons,we generated aGNRH1-TdTomato reporter in the previously
characterized human induced pluripotent stem cell (iPSC) line
HEL11.4 (Mikkola et al., 2013) using CRISPR-Cas9. Before the
GNRH1 stop codon, we knocked-in a reporter sequence encoding
a 2A self-cleaving peptide followed by nuclear signal-tagged
TdTomato. Homologous recombination of the donor template in
the endogenous locus was stimulated using CRISPR-Cas9 targeting
adjacently to the GNRH1 stop codon (Fig. 1A). Altogether, 11
correctly integrated clones were isolated, and one clone (‘A4’)
(Fig. 1B) was selected for differentiation into GNRH1-expressing
neurons according to our previously published protocol (Lund et al.,
2016) (Fig. 1C,D). At the end of the protocol, we observed bipolar
cells with neuronal morphology that contained the fluorescent
TdTomato signal (Fig. 1C), and after immunocytochemistry, we
confirmed that the TdTomato signal indeed coincided with anti-
GnRH antibody (Fig. 1D). The reporter sensitivity was ∼50%
(Fig. 1E), which may reflect differences in GnRH and TdTomato
peptide turnover, presence of cells in the culture which are devoid
of the TdTomato sequence or allelic switch (Miyanari and
Torres-Padilla, 2012). We performed RNA-seq of the TdTomato-
positive and negative cells after FACS to investigate their differential
expression. We detected 264 differentially expressed genes (P-value
<0.05) in TdTomato-positive versus -negative samples (n=3) and, out
of 67 upregulated genes, GNRH1 had the second highest log fold
change (Table S1). In addition to GNRH1, the upregulated genes
included the KS gene ANOS1 (Hardelin et al., 1999), as well as
CAMK2A, GAD1, GRIA1, GRIA2, GRIA4 and SEMA6D (Fig. 1F),
expression of which has been previously described in GnRH neurons
of animal models (Yang-Feng et al., 1986; Cariboni et al., 2004;
Vastagh et al., 2016; Heger et al., 2003; Di Giorgio et al., 2013;
Spergel et al., 1999; Bailey et al., 2006; Ebert et al., 2012). These
results indicate that TdTomato-expressing neurons successfully mark
the formation of GnRH neurons during differentiation from hPSCs.
In accordance with these results, the reporter cell line generation
was successfully repeated in H9 human embryonic stem cells
(ESCs), exhibiting co-expression of TdTomato and anti-GnRH
immunopositivity after differentiation on day 25 (Fig. S1).
RNA-seq reveals differences between FGF8-treated
progenitor pool and TdTomato-expressing GnRH neuron
mRNA transcriptomes
To further characterize the mRNA transcriptome of TdTomato-
expressing GnRH neurons, we analyzed samples from two time
points of the differentiation protocol, as indicated in Fig. 2A. First,
we included the FGF8-treated neuronal progenitor cell pool
(D20FGF8). These contain anteriorly patterned neuronal
progenitors, with competence to give rise to GnRH neurons after
treatment with Notch inhibitor DAPT (Lund et al., 2016). Second,
to investigate the effect of FGF8 treatment, we also included cells
not treated with FGF8 (D20FGF8nt) representing neuronal
progenitors without specific priming into any distinct neuronal
lineage. Finally, we included TdTomato-expressing GnRH neurons
(D27TdT+) after FACS sorting at day (D)27 (Fig. 2A). We
performed differential expression analysis in three sets of
Fig. 1. Generation of GnRH-TdTomato reporter cell line in hPSCs. (A) Donor template insertion into hPSC genomic DNA was targeted to the last exon of
GNRH1. The donor template contained T2A self-cleaving peptide and nuclear localization signal (NLS) for cleavage and transportation of TdTomato protein
into the nucleus, leaving the GnRH peptide intact. (B) PCR spanning the homologous arm integration into hPSC genomic DNA by the 5′ and 3′ homologous arm
junction sites. (C) TdTomato-expressing neurons after differentiation to GnRH neuron lineage. BF, brightfield. (D) Anti-GnRH immunocytochemistry of TdTomato-
expressing cells at day 27 of differentiation. (E) Reporter efficiency calculated based on GnRH antibody staining and TdTomato in the same cells (n=3,
mean±s.d.). (F) RNA-seq of TdTomato-positive versus TdTomato-negative cells (n=3) at day (D)25 revealed upregulation of eight genes that have previously
been described in GnRH neurons.
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Fig. 2. See next page for legend.
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comparisons between each sample (n=4) (Fig. 2B), to encompass
the differences in gene expression between the progenitor pool and
differentiated GnRH neurons (analysis 1), as well as the effect of
FGF8 treatment during differentiation (analyses 2 and 3).
We first focused on investigating the differences between D20
FGF8-treated progenitors and differentiated GnRH neurons.
Comparing D27TdT+ with D20FGF8, GNRH1 was found to be the
tenth most upregulated gene (log fold change: 5.2, P-value:
1.99×10−7) among the 2769 other significantly upregulated and
3692 downregulated genes. Within the top 50 upregulated and
downregulated genes (Fig. 2C, Table S2), several have been previously
implicated in the timing of puberty, and/or their expression in GnRH
neurons has been confirmed in animal models (Table S3). We
validated the mRNA expression of 10 out of the top 50 upregulated
genes; RELN, SEMA3C, RBFOX1, PLXNA2, SCN2A, TAC1,GNRH1,
MYT1L,BCL11B, ISL1 by qPCR (Fig. S2), and illustrated the presence
of RBFOX1, SEMA3C, DSCAM, SCN2A, PLXNA2, substance P
(TAC1) and PTPRN2, at protein level in GNRH1-expressing neurons
after 27 days of differentiation (Figs S3-5).
To compare the differences between all upregulated and
downregulated genes, we next performed over-representation
analyses to find the most enriched Gene Ontology (GO)
biological processes (Fig. 2D). Most over-represented processes
in the upregulated genes were related to neuronal maturation,
migration or function, including hormone secretion, whereas the
downregulated categories were related to stem cell state, cell cycle
and morphogenesis. This agrees with our previous observations that
the FGF8-treated cell pool at D20 consists of undifferentiated
progenitor cells and, by D27, GnRH neurons have acquired
neuronal morphology and secrete GnRH decapeptide (Lund et al.,
2016; Yellapragada et al., 2019). We next asked whether there are
any known interactions within the differentially regulated genes
themselves that could represent potential regulatory pathways
during GnRH neuron differentiation. We found only 10
previously reported interactions within the top 50 upregulated
genes, five of them being direct interactions between SEMA6D-
PLXNA4 (protein-protein), GAD1-GAD2 (protein-protein),
GRID2-GRIA2 (localization, protein-protein), RELN-BCL11B
(expression) and MYT1L-RBFOX1 (protein-DNA, transcription)
(Fig. 2E, Table S4). A larger number of interactions were, however,
found within the top 50 downregulated genes (Fig. 2F, Table S4),
many of which have known roles in sustaining proliferation and
repressing differentiation in the progenitor pool, such as NOTCH1,
NOTCH2, HES5, SOX2, YAP2 and MKI67 (Herrick et al., 2018;
Panaliappan et al., 2018; Huang et al., 2005; Sobecki et al., 2016).
We next asked whether some of the upregulated transcription factors
have features of potential master regulators, by exhibiting larger
numbers of downstream interactions in the data. To explore this
effect, we constructed a pathway containing transcription factors
in the top 50 upregulated gene list (EBF1, MYTL1, BCL11B,
RUNX1T1, ISL1 and DLX6) and their reported downstream
interaction to the top 500 upregulated genes (Fig. S2). Out of
these transcription factors, ISL1, a LIM/homeodomain family
transcription factor with a known role as a specifying transcription
factor in early spinal motor neurons (Rhee et al., 2016; Cave and
Sockanathan, 2018), displayed the most known downstream
interactions within the top 500 upregulated genes (Fig. S6). We
searched for reported interactions with ISL1 represented in the
RNA-seq data, and found ‘protein-protein’, ‘protein-DNA’,
‘expression’ and ‘activation’ interactions upstream and
downstream of ISL1 within the differentially expressed genes
(Fig. 2G). Together, the transcriptome data and knowledge-based
interaction pathways offer prediction of some of the putative
mechanisms involved in GnRH neuron differentiation, and suggest
a role for ISL1 in regulating the expression of effector genes during
GnRH neuron differentiation.
ISL1 in hPSC-derived GnRH neurons and human fetal GnRH
neurons
To confirm ISL1 protein expression in human GnRH neurons, we
performed immunocytochemistry for ISL1. In accordance with the
RNA-seq results, nuclear ISL1 was present in α-GnRH-positive
neurons at D27 of the differentiation (Fig. 3A). ISL1 was not
detected in D20 progenitor cells, which suggests that ISL1 becomes
expressed in postmitotic neurons. We then analyzed by triple-
immunofluorescence the expression pattern of ISL1 in human
fetuses [10.5 gestational weeks (GW), n=2] together with the
expression of GnRH and transient axonal glycoprotein 1 (TAG-1;
also known as contactin 2; Fig. 3B-G), which highlights the axonal
scaffold for the migration of GnRH neurons (Yoshida et al., 1995;
Casoni et al., 2016).
All GnRH-immunoreactive neurons expressed ISL1 throughout
the migratory pathway, both in the nasal compartment (Fig. 3B-D)
and in the brain septal area (Fig. 3E-G). These results indicate that
ISL1 is expressed in fetal GnRH neurons after their differentiation,
and expression of ISL1 persists during the migration to the
hypothalamus.
Presence of genes implicated in CHH in mRNA profiles of
hPSC-derived GnRH neurons
To compare the current knowledge about CHH genetics with this
model, we searched our RNA-seq data for a list of 37 reported CHH
genes (Fig. 4A), including the genes associated with both KS (i.e.
anosmic phenotype) and normosmic CHH (Boehm et al., 2015;
Bouilly et al., 2018; Howard et al., 2016; Xu et al., 2017; Richards
et al., 2017; Kotan et al., 2018). We found 15 validated CHH genes
differentially expressed in D27TdT+ versus D20FGF8 (Fig. 4B).
Netrin 1 (NTN1) and its receptor deleted in colorectal cancer (DCC)
are known to be involved in GnRH neuron migration during
embryonic development, and DCC expression has been reported in
GnRH neurons (Low et al., 2012; Bouilly et al., 2018; Schwarting
et al., 2004). Also plexin-A1 (PLXNA1), receptor of class 3
Fig. 2. RNA-seq at two time points of differentiation toward GnRH
neurons. (A) The GnRH neuron differentiation protocol begins with 10 days
Dual Smad inhibition (DM+SB), followed by 10 days FGF8 treatment to
differentiate anteriorly patterned neuronal progenitor cells. To investigate the
effect of FGF8 on the RNA profile of the cells, we collected FGF8-treated and
non-treated cells at day (D)20. The final seven days of the protocol included
Notch inhibition by DAPT. Based on TdTomato reporter expression, we
collected the D27 TdTomato-positive samples by FACS sorting on D27.
(B) RNA-seq and differential expression analyses were performed between
these samples (n=4) in three paired comparisons. (C-G) Results from
D27TdT+ versus D20FGF8 differential gene expression analysis.
(C) Transcriptome of GnRH neurons versus FGF8-treated progenitor pool,
showing the top 50 upregulated (red, top) and downregulated (green, bottom)
genes differentially expressed in D27TdT+ versus D20FGF8. Genes
previously implicated with an association to puberty timing or expression in, or
in close association with, newly formed GnRH neurons (animal models) are
indicated (+). (D) Top 20 GO biological processes, and the number of genes
per category, enriched in all the significantly upregulated (red, left) and
downregulated (green, right) genes D27TdT+ versus D20FGF8. IPAwas used
to draw a pathway containing connections within top 50 upregulated (E) and
downregulated (F) genes, and their cytoplasmic localization. (G) IPA pathway
of ISL1 upstream and downstream interactions represented in differential
expression analysis 1. Lfc, log fold change. See Tables S3,S4 for references
associated with panels C, E, F and G.
4
RESEARCH ARTICLE Disease Models & Mechanisms (2020) 13, dmm040105. doi:10.1242/dmm.040105
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
semaphorins, is involved in GnRH neuron embryonic migration in
mice (Cariboni et al., 2007; Marcos et al., 2017). To our knowledge,
expression of PCSK1, FGF17 and POLR3B has not been previously
reported in GnRH neurons specifically. PCSK1 and POLR3B are
associated with normosmic CHH (Pepin et al., 2018; Richards et al.,
2017), but FGF17 mutations are associated with KS and anosmia,
which implies a role during early GnRH neuron migration from the
olfactory placodes as well (Valdes-Socin et al., 2014). Interestingly,
eight of these 15 genes were among the downregulated genes, which
implies higher expression in the progenitor pool. A possible
explanation is a role for these genes in the earlier phases of
differentiation, or within the niche of developmentally related
neuronal progenitors. In accordance, HESX1, FGFR1, ANOS1 and
FEZF1 expression has been reported in the nasal placodes
(Carvalho et al., 2003; Chung et al., 2008; Hirata et al., 2006;
Kotan et al., 2014), PROK2 and AXL along the GnRH neuron
migratory route (Pitteloud et al., 2007; Allen et al., 2002; Pierce
et al., 2008), and TAC3 and TACR3 are expressed by hypothalamic
kisspeptin/neurokinin B/dynorphin (KNDy) neurons (Navarro and
Tena-Sempere, 2011). In conclusion, several genes implicated in
CHH and associated with early stages of GnRH neuron
development were present in this data, including nine genes that
Fig. 3. ISL1 expression in hPSC-derived and human fetal GnRH neurons. (A) Immunocytochemical staining with ISL1 and GnRH antibodies at day 27 of
differentiation showed nuclear staining of ISL1 in GnRH-positive neurons. Result has been replicated in 3 experiments. (B) Schematic of a GW10.5 human fetus
head (coronal view). Box indicates the area represented in immunohistochemical staining in C and D. (C,D) GnRH (green), ISL1 (red) and TAG-1 (white)
expression in a coronal section of a GW10.5 fetus. ISL1 is expressed in GnRH neurons located in the nose and entering the forebrain (olfactory bulbs, OB).
D shows a magnified view of the boxed area in C. (E) Schematic of a GW10.5 human fetus brain (coronal view). Box indicates the area represented in
immunohistochemical staining in F and G. (F,G) ISL1 (red) is expressed in GnRH neurons that have migrated into the forebrain (septum). G shows a magnified
view of the boxed area in F. White arrows showGnRH/ISL1 double-labeled cells. Arc, arcuate nucleus; OE, olfactory epithelium; LV, lateral ventricle; NEP: neuro-
epithelium; 3V: third ventricle. Scale bars: 50 µm in A; 250 µm in C,F; 20 µm in D; 40 µm in G.
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are associated with KS and anosmia, suggesting involvement in
embryonic GnRH neuronal migration from the olfactory placode.
Genes expressed after treatment with FGF8 in progenitors
and GnRH neurons
At D20, FGF8-treated progenitor cells organize in neuronal rosettes
that express proliferation marker Ki67 (MKI67) and neuronal stem
cell/progenitor cell marker SOX2. Cells grown without FGF8 usually
have fewer and smaller neuronal rosettes, and already show
presence of some bipolar neuron-like cells, but do not produce
GnRH-expressing cells at the end of the protocol (Lund et al., 2016).
In accordance, FGF8 has a known role in promoting stem and
progenitor cell survival and proliferation (Tucker et al., 2010; Diez del
Corral et al., 2002). To identify the effects of FGF8 treatment on
mRNA expression, we next examined differential expression between
FGF8-treated and non-treated samples (Fig. 5A). We performed
differential gene expression analysis ofD20FGF8versusD20FGF8nt,
to investigate the effects of FGF8 in the progenitor pool, and
differential gene expression of D27TdT+ versus D20FGF8nt, to
determine putative effects of FGF8-treament which are also sustained
in postmitotic GnRH neurons. Finally, to identify overlap within
significantly upregulated genes in FGF8-treated samples, we
combined the results of upregulated genes from these two analyses
(Fig. 5B). We found 37 upregulated and 61 downregulated genes that
were overlapping in bothD20FGF8versusD20FGF8nt andD27TdT+
versus D20FGF8nt (Table S7). Out of the 37 overlapping genes
upregulated in both analyses (Fig. 5C), seven geneswere also found to
further increase expression in TdTomato-expressing GnRH neurons
(DUSP4,GIPR, BAIAP3,DRP2,MPPED2, LINC01844 andDLG2),
suggesting that these genes have been upregulated in the FGF8-treated
neuronal progenitors and their expression has remained and/or
increased after GnRH neuron specification. The most upregulated
gene inD27TdTomato-expressingGnRHneurons in this comparison,
DUSP4, is a member of the dual specificity protein phosphatase
family, which negatively regulate members of MAPK superfamily
(Niwa et al., 2007) and also regulate neuronal differentiation inmouse
ESCs by linking theMapk/Erk and calcium signaling pathways (Kim
et al., 2015). Also the transcription factor FOXG1 was among the
Fig. 4. CHH-associated genes
differentially expressed in TdTomato-
expressing GnRH neurons and their
progenitors. (A) Table of known
CHH-associated genes and their
occurrence in the RNA-seq analyses.
Arrows up or down indicate upregulated
and downregulated genes, respectively.
Differential expression was detected for
LEPR and DMXL2, although their log
fold change values (lfc) were below the
threshold that was set as significant
(>1 and <−1), and are therefore marked
in the table. No entry indicates that
differential gene expression was not
detected. (B) Known CHH-associated
genes present in D27TdT+ versus
D20FGF8 differential gene expression.
Positive lfc indicates that the gene was
significantly upregulated in GnRH
neurons, negative lfc indicates that the
gene was significantly upregulated in the
progenitor pool. Asterisks indicate
association of gene mutations to KS
(featuring anosmia) or normosmic (n)
CHH.
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Fig. 5. Overlap in genes upregulated by FGF8-treatment in D20 progenitors and GnRH neurons. (A) Examination of the differential gene expression in
analyses of D20FGF8 versus D20FGF8nt and D27TdT+ versus D20FGF8nt, to describe the effect of FGF8 treatment. (B) There was an overlap of 37 genes
upregulated in both analyses. (C) List of 37 overlapping genes that were upregulated and their respective log fold changes. (D) IPA pathway analysis
of known downstream effectors of FGF8, present in differential expression analysis D20FGF8 versus D20FGF8nt. (E) IPA pathway analysis of known genes
upstream ofGNRH1 present in D27TdT+ versus D20FGF8nt. Shapes in E are as indicated in Fig. 2. See Table S8 for references associated with interaction data
presented in panels D and E.
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common upregulated genes, and supports our previous observation of
high FOXG1 mRNA and protein expression in neuronal progenitors
following FGF8 treatment (Lund et al., 2016). Furthermore, one of
these 37 overlapping genes, FGF13, was recently reported to be
enriched in mouse GnRH neurons by RNA-seq (Burger et al., 2018),
and also described as a CHH candidate gene (Quaynor et al., 2016).
To explain the role of FGF8 in inducing gene expression changes
that could ultimately lead to specification of GnRH neurons, we
used Ingenuity Pathway Analysis (IPA) to predict the upstream
effect of FGF8 based on known interactions. In D20FGF8 versus
D20FGF8nt, we found 10 known downstream effectors of FGF8
signaling present in the data, also including the aforementioned
FOXG1 (Fig. 5D, Table S8). Based on these downstream effectors,
FGF8 action within the neuronal progenitor cells is likely
implemented in part by upregulated expression of FOXG1, LHX8,
SPRY2 and TNXB. FGFR2 downregulation was represented in both
D20FGF8 versus D20FGF8nt and D27TdT+ versus D20FGF8nt
(Table S7). FGF8 acts through cognate receptors FGFR1 and
FGFR3, and cell type-specific regulation of receptor-type
expression by FGF8 has been demonstrated (Mott et al., 2010).
This regulation of receptor expression is likely to further influence
the activation of downstream intracellular pathways.
When compared to the D20FGF8nt samples, TdTomato-
expressing GnRH neurons, which are differentiated from the
FGF8-treated progenitor pool, revealed upregulation of genes
associated with several GO biological processes related to neuronal
differentiation and function (Fig. S7), and we next asked whether
some of these genes have any reported direct interactions upstream of
GNRH1. We found TLE4, SOX11, MEF2C, GAL, GAD1, CPE and
GPR173 among the upregulated genes (Fig. 5E, Table S8). SOX11
has been demonstrated to activateGNRH1 gene expression inmurine
immortalized GnRH neuronal cells (Kim et al., 2011), whereas
MEF2C is involved in suppression of GnRH expression during
embryonic migration (Allen et al., 2000, 2002). GPR173 is a G
protein-coupled receptor for phoenixin peptide, which was recently
found to increase GnRH expression in a murine immortalized
hypothalamic GnRH neuron cell line (Treen et al., 2016). In
conclusion, some of the candidate genes presented in these results
may play important roles in the regulation of GNRH1 expression
during GnRH neuron differentiation and maturation processes.
DISCUSSION
During human fetal development, GnRH neurons differentiate from
the nasal neuroepithelial compartment, which is derived from the
olfactory placodes, and begin their migration to the hypothalamus
(Casoni et al., 2016). These newly formed postmitotic embryonic
GnRH neurons express GNRH1 and neuronal markers such as
DCX, β-tubulin III and DNER, as they emerge just outside the
presumptive vomeronasal organ, which contains SOX2 and Ki67-
positive putative precursor cells. The questions of the identity and
distinctive markers for the neuronal progenitor subtype still remain
to be answered. The primary objectives of using hPSCs for
differentiation of GnRH neurons is to model GnRH neuron
development and provide a platform to study the biological
mechanisms that regulate GnRH neuron differentiation. CRISPR-
Cas9 genome editing has recently become one of the central
methods in biomedical research, with benefits for stem cell research,
disease modeling and studying differentiation of specialized cell
types including GnRH neurons (Yellapragada et al., 2019).
To compare our hPSC-derived model for human GnRH neuron
development to previously performed characterization of GnRH
neurons, we compared our data to previously reported genes from
animal models and found that many of these were indeed present
among the differentially expressed genes, which included genes
implicated in CHH, GnRH neuron and olfactory placode markers.
This is of particular interest as the disease mechanisms of CHH and
milder forms of pubertal delay are largely unknown, and disease-
modeling with hPSCs is expected to reveal such mechanisms. For
example, with the aid of CRISPR-mediated gene editing and
activation (CRISPRa) (Weltner et al., 2018) it will be possible to
investigate how altered expression of a single gene or a set of genes
enriched in our transcriptome data affect human GnRH neuron
specification and GnRH secretion (Lund et al., 2016). Conversely,
researchers working with exome and whole genome sequencing
data from CHH patients might find our data useful when attempting
to deduce the pathogenic and causative variants in their data sets.
Finally, the use of patient-derived iPSCs in combination with
CRISPR genome editing will allow investigation into the relative
contribution of multiple rare sequence variants acting either alone or
in combination (i.e. oligogenecity; Young et al., 2019) affecting
GnRH cell phenotype.
On the other hand, when we searched for previously published
interactions within the differentially expressed genes between
TdTomato-expressing GnRH neurons and the progenitor pool, we
noticed a substantially lower number of interactions within the
group of upregulated genes. The small number of reported
interactions itself reflects the complexity of mechanisms
governing GnRH neuron development that are yet to be
described. Among the top 50 upregulated genes in TdTomato-
positive GnRH neurons were SEMA6D and PLXNA4 (Fig. 2C,E),
with a previously reported protein-protein interaction (Toyofuku
et al., 2004). In accordance, semaphorin-plexin signaling is known to
be crucial for embryonic GnRH neuron migration (Lettieri et al.,
2016). RBFOX1, one of the upregulated genes in TdTomato-
expressing neurons, also detected by immunocytochemistry
(Fig. S3) has not been previously described in GnRH neurons, but
is known to regulate neuronal development and subtype specification
by alternative splicing (Wamsley et al., 2018), and its interactor
MYT1L has been described as a pan neuronal transcription factor that
represses non-neuronal fates during differentiation (Mall et al., 2017;
Hu et al., 2013). A role for BCL11B in the regulation of the
expression of reelin (RELN) has been previously suggested, during
the differentiation of mouse medium spiny neurons (Arlotta et al.,
2008). Interestingly, BCL11B has been presented as a candidate gene
to regulate puberty timing (Day et al., 2017), and Bcl11b expression
has been reported in mouse vomeronasal neurons during embryonic
development (Enomoto et al., 2011), whereas RELN has been
implicated in migration of GnRH neurons (Dairaghi et al., 2018;
Cariboni et al., 2005).
Among the highly upregulated genes in TdTomato-expressing
GnRH neurons was the transcription factor ISL1, and its expression
in human postmitotic GnRH neurons was confirmed in fetal tissues.
ISL1 is known to regulate gene expression by forming protein
complexes with transcription factors such as LIM domain-
containing factors (Caputo et al., 2015; Gay et al., 2000). The
protein-protein and protein-DNA interactions of ISL1 have the
specific outcome of activating downstream neuron subtype-specific
genes (Lee et al., 2016; Rhee et al., 2016; Zhang et al., 2018). This
raises the possibility that ISL1, in co-operation with other yet-to-be-
defined transcription factor(s), functions as a master regulator in
GnRH neurons during their terminal differentiation. We found 49
reported interactions between ISL1 and the genes represented in the
RNA-seq data. These included for example PBX1, a suggested
repressor ofGNRH1 expression (Rave-Harel et al., 2004). Together,
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this advocates for ISL1 involvement in regulating gene expression
during GnRH neuron differentiation, which is likely to be cell type-
specific, and further studies are needed to determine its mechanism
of action during GnRH neuron development.
FGF8 signaling through FGFR1 is indispensable for the
neurogenesis of GnRH neurons (Kawauchi et al., 2005; Falardeau
et al., 2008; Chung et al., 2008), suggesting an important role for
FGF8 during GnRH differentiation. The olfactory placode in mice,
the neurogenic niche that is known to give rise to GnRH neurons,
lies in an area in the ventral olfactory placode that is patterned by
mesenchymal and epidermal sources of FGF8, BMP and noggin
(Forni et al., 2013; Forni et al., 2011). The neurogenic permissive
area is first established by the mesenchymal-derived BMP/TGFβ
inhibition, in which FGF8 acts as a pro-neurogenic factor by having
an indirect effect on the positioning of the GnRH neuron progenitor
niche, by modulation of signals from the mesenchymal patterning
centers (Forni et al., 2013). We have found that FGF8 treatment
stimulates the hPSC-derived neuronal progenitor’s ability to
produce GnRH neurons in vitro, but the specific downstream
influences of FGF8 treatment are not fully resolved. We previously
showed that FOXG1 expression becomes upregulated during the
FGF8 treatment (Lund et al., 2016). Accordingly, we have now
observed that the genes differentially expressed following FGF8
treatment also included FOXG1. FOXG1 expression is known to be
regulated by FGF8 in the developing brain (Shimamura and
Rubenstein, 1997; Storm et al., 2006; Diez del Corral et al., 2002;
Lund et al., 2016), and FOXG1 expression in the neurogenic niche
in the nasal pit has been reported as one of the requirements for
proper GnRH neuron development (Garaffo et al., 2015; Duggan
et al., 2008). FGF8 treatment of the differentiating progenitor pool
should therefore lead to downstream changes in gene expression,
which subsequently lead to the establishment of a GnRH neuron
progenitor lineage during hPSC differentiation. In an effort to
identify some of the downstream effector genes, we compared the
differential expression analyses of FGF8-treated versus non-treated
samples and found 37 genes as likely downstream targets
responding to FGF8 signaling. DUSP4 stood out with the largest
fold-increase in TdTomato-expressing cells, at D27 when GnRH
neurons have differentiated. DUSPs have known roles in negative
regulation of the MAPK/ERK pathway (Caunt and Keyse, 2013)
and have been reported in the regulation of neuronal development
and axonal growth through modulation of ERK activity (Finelli
et al., 2013). Dusp4 expression reportedly increases during neuronal
differentiation in mouse ESCs, where its knockdown affected the
ERK activity. This resulted in changes in calcium signaling pathway
activity, which was suggested to be the mechanism that regulates
neurite growth and neural marker expression in these cells (Kim
et al., 2015). In our transcriptome data, calcium ion transmembrane
transport was one of the top 20 enriched biological processes in
TdTomato expressing GnRH neurons (Fig. 2D), which suggests
calcium signaling being actively regulated in these cells. A
potentially interesting aspect is to further investigate whether
calcium signaling serves as a mechanism through which FGF8 and
Notch pathways regulate neuronal differentiation. Besides, another
dual specificity protein phosphatase, DUSP6, could play an
important role during GnRH neuron development. Mutations in
DUSP6 have been identified in normosmic CHH and KS patients,
when candidate genes were screened in patient samples based on
similar expression patterns and protein interaction within the FGF8
pathway ‘synexpression group’ (Miraoui et al., 2013). Indeed,
Dusp6 expression has been reported in the nasal placodes during
mouse embryo development (Dickinson et al., 2002). In addition to
negative regulation ofMAPK signaling (Li et al., 2007), DUSP6 has
been suggested to modulate calcium-dependent neurotransmitter
release homeostasis by downregulation of L-type calcium channel
Cav1.2 expression (Mortensen, 2013). Considering these findings,
the DUSP-family proteins may be players in modulating FGF8
activity during GnRH neuron differentiation.
In conclusion, we present data describing the hPSC-derived
GnRH neuron transcriptome, and as a contribution towards better
understanding of GnRH neuron development and differentiation,
we expect that these data will lead to broader validation of new
genes pertinent to GnRH neuron function.
MATERIALS AND METHODS
Generation of GNRH1-TdTomato reporter knock-in to HEL11.4
TheGNRH1-TdTomato reporter cell linewas generated using CRISPR-Cas9
genome editing (Balboa et al., 2017) with the strategy to target the
stop codon at the GNRH1 gene for insertion of the donor template
GNRH1_T2A_NLS_TdT_PGK_puro. The donor template was designed
with 577 (5′) and 599 bp (3′) homologous arms to introduce the donor
sequence into the genome by homologous recombination. The homologous
arms were cloned by PCR from the genomic DNA of the human embryonic
stem cell line H9 with primers containing BamH1 and Nhe1 (5′ homologous
arm) and Ascl1 and Xba1 (3′ homologous arm) restriction sites for cloning.
The fragments were PCR purified (NucleoSpin Gel and PCR Clean-up,
Macherey-Nagel) and digested. The fragments were then purified from
agarose gel and ligated to the donor template vector T2A-2xNLS-TdTomato-
PGK-Puro. Guide RNA sequences were designed using crispr.mit.edu/
Guides and the guide cassettes were amplified and purified as described
previously (Balboa et al., 2017). Guide sequence and homologous arm
primers sequence are provided in Supplementary Materials and Methods.
Electroporations and clonal expansion of knock-in iPSC clones
HEL11.4, a previously characterized human iPSC line [Biomedicum StemCell
Centre (BSCC)] (Mikkola et al., 2013) were grown in Stem Pro (Thermo Fisher
Scientific) and were dissociated using Accutase (Life Technologies) and
resuspended in cold 5% fetal bovine serum (FBS)/PBS. Three electroporations
were performed using Neon Transfection system (Life Technologies) according
to themanufacturer’s instructions,with a total of 6×10E6 cellswith 18 µgCAG-
Cas9 (gift from Diego Balboa, Biomedicum Stem Cell Centre, Finland;
Addgene plasmid #89995), 6 µg pUC-GNRH1-T2A-NLS-TdT-PGKPuro and
1.5 µg guideRNAusing a pre-optimized program (1100V, 20 ms, 2 pulses) and
plated onto Matrigel (Corning) matrix-coated dishes with 10 μM ROCK
inhibitor (Y-276322HCl,Selleckchem) inStemPro (LifeTechnologies).On the
following day, medium was changed to Stem Pro with 5 μM ROCK inhibitor.
ROCK inhibitor was removed after 48 h, and selection with 0.15 µg/ml
Puromycin (Sigma-Aldrich)was started 72 h after electroporation.Mediumwas
refreshed daily until colonies established. Colonies were picked on Matrigel-
coated 96-well plates in Stem Pro+5 µM Rock inhibitor ∼7-10 days after
electroporation. All cell lines have been tested for mycoplasma contamination.
Screening of knock-in clones
For collection of DNA samples, cell colonies in 96-well plates were treated
with 0.5 mM EDTA (Invitrogen) for 4 min, after which the EDTA was
removed and replaced with 100 µl Stem Pro+10 µM ROCK inhibitor, and
the cells were detached from the plate by scraping with a 10 µl pipette tip.
From each well, 50 µl of cell suspension was left in a flat-bottomed 96-well
plate for continued culture and freezing, whereas the other 50 µl was moved
to a V-bottom plate. The V-bottom plate was centrifuged at 2300 rpm
(889 g) for 3 min, and supernatant removed. Then 60 µl PCR Direct
lysis buffer (Viagen Biotech) and 5 µl Proteinase K (Viagen Biotech) was
pipetted to each well, and the plate was incubated at 55°C for 2 h and 85°C
for1 h, and frozen at −20°C until use. Touchdown PCR for detection of
integration of the 5′ and 3′ homology arms was performed using the primers
and conditions listed in Supplementary Materials and Methods.
The reporter cell line generation was repeated in the hPSC line H9
(WiCell) according to the methods described above. One successful clone
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(‘C11’; Fig. S1) was used, together with the original clone, during validation
of the RNA-seq results.
GnRH-neuron differentiation of knock-in clones
Three confirmed knock-in clones were thawed for GnRH neuron
differentiation which was performed as described in Lund et al. (2016).
Briefly, cells were expanded in Stem Pro on Geltrex-coated (Life
Technologies) culture dishes. Differentiation started at 90% confluence, in
N2B27+2 µMDorsomorphin (Selleckchem) and 10 µMSB431542 (Sigma-
Aldrich). On day 10, cells were passaged, and medium changed to
N2B27+100 ng/ml FGF8 (Peprotech). At day 20, cells were passaged, and
medium was changed to N2B27+100 ng/ml FGF8+20 µM DAPT
(Selleckchem), until FACS sorting or sample collections on D25 or D27.
FACS
For single cell suspension, cells were washed with PBS and incubated with
Accutase for 5 min at 37°C, three volumes of 10% FBS (Life Technologies)
in PBS was added, and then centrifuged for 3 min at 200 g. Cells were
resuspended in FACS buffer [10% FBS, 2 µM EDTA, 0.625 mM HEPES
buffer (Sigma-Aldrich) and 10 µM ROCK inhibitor in HBSS (Life
Technologies)] at ∼1.5-2 million cells/ml, and transferred to 5 ml Falcon
tube with a cell strainer snap cap (Falcon). FACS sorting was performed
using and SH800 cell sorter (Sony Biotech), and TdTomato-expressing cells
were collected into Eppendorf tubes. At least 2000 cells were collected per
sample for RNA isolation.
qPCR
Total RNAwas extracted using RNAqueous micro Total RNA Isolation kit
(Thermo Fisher Scientific). mRNA was reverse transcribed using iScript™
cDNA Synthesis Kit (Bio-Rad, 170-8891). Real-time quantitative PCR was
performed with cDNA using HOT FIREPol® EvaGreen® qPCR Mix Plus
(Solis BioDyne) and LightCycler® 480 (Roche) for 45 cycles of 95°C for
15 s, 60°C for 20 s and 72°C for 20 s. mRNA expression was normalized to
cyclophilin G (PPIG) and all the primers used are listed in Table S5.
Immunocytochemistry
Cells were plated and grown on Geltrex-coated glass slides until fixation.
First, cells were pre-fixed with 4% paraformaldehyde (PFA) (∼1:1 ratio)
into cell culture medium for 5 min, washed with PBS, treated with 4% PFA
for 17 min and then washed 3-4 times in PBS. For staining, cells were
permeabilized with 0.05% Triton X-100 (Sigma-Aldrich) in PBS for 7 min
and blocked with Ultra Vision Protein Block (Thermo Fisher Scientific).
Primary antibodies used were: rabbit polyclonal anti-ISL1 antibody
(Abcam, ab20670, 1:500) and guinea pig anti-GnRH antibody (EH#1018,
1:8000; a generous gift from Dr Erik Hrabovszky, Laboratory of Endocrine
Neurobiology, Institute of Experimental Medicine, Hungarian Academy of
Sciences, Budapest, Hungary; Hrabovszky et al., 2011; Skrapits et al.,
2015). Primary antibodies were diluted in, and washed with, 0.1% Tween
(Sigma-Aldrich) in PBS, and then incubated overnight at 4°C. Secondary
antibodies used were: Alexa Fluor 488 donkey anti-rabbit (Life
Technologies, 1:500, A21206) and Antibody-CF™594 donkey anti-
guinea pig (Sigma-Aldrich, 1:1000, SAB4600096). Secondary antibodies
were incubated for 35 min at room temperature, DAPI (Sigma-Aldrich)
stained for 1 min, and slides were mounted with ProLong Diamond
AntifadeMountant (Molecular Probes). The H9 human embryonic stem cell
line (WiCell), withoutGNRH1-TdTomato reporter, was used to detect ISL1
in Fig. 3, as well as the immunocytochemistry presented in Figs S3-5, which
were performed according to the same protocol. The complete list of
antibodies, and their dilutions, are presented in Table S6. Images were
captured using a Zeiss AxioImager.Z1 upright epifluorescence microscope
and Zen Blue (Zeiss). Images were processed using ImageJ (brightness and
contrast, cropping for better visibility of region of interest).
Human tissue collection and processing
Two human fetuses (10.5 GW, post amenorrhea) were obtained with the
parents’ written informed consent (Gynaecology Hospital Jeanne de
Flandres, Lille, France). Permission to use non-pathological human fetal
tissues was obtained from the French Agency for Biomedical Research
(Agence de la Biomédecine, Saint-Denis la Plaine, France, protocol no.
PFS16-002). Tissues were made available in accordance with the French
bylaw (Good practice concerning the conservation, transformation and
transportation of human tissue to be used therapeutically, published on
December 29, 1998).
Immunohistochemistry on human tissues
Human fetuses (10.5 weeks post amenorrhea, n=2) were immersion-fixed in
4% PFA in 0.1 M PBS (pH 7.4) for 1 week at 4°C, cryoprotected in 30%
sucrose in PBS for 48 h, embedded in Tissue Tek (Miles) and frozen in
liquid nitrogen. Tissues were cryosectioned at 18 μmusing a CM3050 Leica
Cryostat. Localization of ISL1 and GnRH was accomplished by using
immunofluorescence procedures as previously described (Casoni et al.,
2016). Briefly, sections were blocked in an incubation solution containing
PBS (pH 7.4) and 0.3% Triton X-100 (TBS-T; Sigma-Aldrich, T8787) with
10% normal donkey serum (NDS; D9663; Sigma-Aldrich) for 2 h at room
temperature. After blocking, sections were incubated for 48 h at 4°C with
primary antibodies in a solution containing 10% normal donkey serum
and 0.3% Triton X100 for 3 days at 4°C. Primary antibodies used were:
rabbit polyclonal anti-ISL1 antibody (Abcam, ab20670, 1:500), guinea pig
anti-GnRH antibody (EH#1018, 1:8000; a generous gift from Dr Erik
Hrabovszky), previously characterized in embryonic and post-mortem
human hypothalami (Casoni et al., 2016; Hrabovszky et al., 2011), and
anti-TAG1 (made in goat, R&D Systems, AF2215, 1:500); 3×5 min washes
in 0.01 M PBS were followed by incubation in appropriately conjugated
secondary antibodies (dilution 1:400): anti-rabbit 568 (made in donkey,
Invitrogen, A10042); anti-guinea pig 488 (made in donkey, Jackson
ImmunoResearch, 706-545-148); anti-goat 647 (made in donkey,
Invitrogen, A21082), for 1 h before incubation with Hoechst 1:1000.
After 3×5 min washes in 0.01 M PBS, sections were coverslipped using
lab-made (in-house) anti-fade mounting medium.
Sections were examined using an AxioImager Z1 ApoTome microscope
(Carl Zeiss) equipped with a motorized stage and an OrcaFlash4.0 CMOS
camera (Hamamatsu). For confocal observation and analyses, an inverted
laser scanning Axio observer microscope (LSM 710, Zeiss) with an EC Plan
NeoFluorÅ∼100/1.4 numerical aperture oil-immersion objective (Zeiss)
was used (Imaging Core Facility of IFR114, of the University of Lille,
France).
RNA-seq
For RNA-seq, total RNAwas extracted using RNAqueous micro Total RNA
Isolation kit (Thermo Fisher Scientific). RNAwas analyzed for concentration,
integrity and quality usingQubit Fluorometer andTapeStation 4200 (Agilent).
Sequencing runs were performed using the Illumina NextSeq500 sequencer
(Illumina) with New England Biolabs Next Ultra Directional polyA capture
method as paired-end sequencing for a read length of 75 bp. The first run
contained D25 FACS-sorted TdTomato±samples (n=3). The second run
contained D20 FGF8-treated, D20 without FGF8 treatment, and D27
TdTomato positive and negative groups (n=4/group). The D27 TdTomato
negative samples were excluded from these comparisons, as it is possible that
some GnRH neurons remained in these samples after FACS, which would
lead to skewed results. RNA-seq and basic bioinformatics were performed at
the Functional Genomics Unit (FUGU), University of Helsinki, Finland.
RNA-seq data analyses
The quality of raw sequencing data in FASTQ format was analyzed using
FASTQC (Simon Andrews, Babraham Bioinformatics, Cambridge, UK)
and quality trimming was performed using Trimmomatic (Bolger et al.,
2014). Reads were then aligned against GENCODE GRCh38 reference
(Harrow et al., 2012) using STAR (Dobin et al., 2013). Quality assessment
was performed using Qualimap (García-Alcalde et al., 2012) and read
counts from bam files were generated using FeatureCounts (Liao et al.,
2013) and annotated with ensemble release 87 using BioMart package in
R (Yates et al., 2016; Durinck et al., 2009). From the raw counts,
normalization and differential expression analysis were performed using
DESeq package in R (Anders and Huber, 2010). We filtered all the
differentially expressed genes, compared to the control, with absolute log
fold change greater than 1 and less than the P-value of 0.05 (Benjamini-
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Hochberg method). In the list of differentially expressed genes, all the
upregulated and downregulated genes (based on their log fold values) were
considered separately for downstream analysis. Over-representation analysis
was performed using Genetrail 2.0 (Stöckel et al., 2016). Bar charts
representingmodified log fold change of differentially expressed genes were
produced using Graphpad Prism7. Gene interaction pathways were drawn
using IPA (Qiagen). (https://www.qiagenbioinformatics.com/products/
ingenuity-pathway-analysis).
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E.-M., Trokovic, R., Kere, J. and Otonkoski, T. (2018). Human pluripotent
reprogramming with CRISPR activators. Nat. Commun. 9, 2643-018-05067-x.
doi:10.1038/s41467-018-05067-x
Wray, S. (2010). From nose to brain: development of gonadotrophin-releasing
hormone-1 neurones. J. Neuroendocrinol. 22, 743-753. doi:10.1111/j.1365-2826.
2010.02034.x
Xu, C., Messina, A., Somm, E., Miraoui, H., Kinnunen, T., Acierno, J., Jr,
Niederlander, N. J., Bouilly, J., Dwyer, A. A., Sidis, Y. et al. (2017). KLB,
encoding beta-Klotho, is mutated in patients with congenital hypogonadotropic
hypogonadism.EMBOMol. Med. 9, 1379-1397. doi:10.15252/emmm.201607376
Yang-Feng, T. L., Seeburg, P. H. and Francke, U. (1986). Human luteinizing
hormone-releasing hormone gene (LHRH) is located on short arm of chromosome
8 (region 8p11.2——p21). Somat. Cell Mol. Genet. 12, 95-100. doi:10.1007/
BF01560732
Yates, A., Akanni, W., Amode, M. R., Barrell, D., Billis, K., Carvalho-Silva, D.,
Cummins, C., Clapham, P., Fitzgerald, S., Gil, L. et al. (2016). Ensembl 2016.
Nucleic Acids Res. 44, D710-D716. doi:10.1093/nar/gkv1157
Yellapragada, V., Liu, X., Lund, C., Känsäkoski, J., Pulli, K., Vuoristo, S.,
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